
Novalgen
Developer of comprehensive immunotherapy platform designed to make biological medicines. The company's platform develops breakthrough bispecific antibody therapies that can safely harness the immune s...
Valuation
$38M
Latest known
Share Price
N/A
Total Raised
$40.4M
Last Round
N/A